Ignite Creation Date:
2024-05-05 @ 7:25 PM
Last Modification Date:
2024-10-26 @ 9:48 AM
Study NCT ID:
NCT00664898
Status:
COMPLETED
Last Update Posted:
2022-12-12
First Post:
2008-04-21
Brief Title:
A Study of the Safety and Pharmacology of SGN-40 Administered in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma
Sponsor:
Organization:
Genentech Inc